Medha Airy1, Tara I Chang2, Victoria Y Ding3, Benjamin A Goldstein4, Nisha Bansal5, Jingbo Niu1, Sankar D Navaneethan1, Mintu P Turakhia6,7, Wolfgang C Winkelmayer1. 1. Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. 2. Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA. 3. Center for Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA. 4. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. 5. Kidney Research Institute, Division of Nephrology, University of Nephrology, Seattle, WA, USA. 6. Cardiovascular Division, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA. 7. Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Abstract
Background: Little is known about the cardiovascular risks of incident atrial fibrillation/flutter (AF) in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD). Methods: We studied older US patients who newly initiated HD for ESRD (2006-11) and who had not previously been diagnosed with AF, stroke, myocardial infarction (MI) or hip fracture. We used Cox regression with AF as a time-varying covariate, adjusted for socio-demographic characteristics and comorbidities to estimate hazard ratios [HRs (95% confidence intervals)] for the events of ischemic stroke, MI and death. Hip fracture served as a negative control outcome. Results: We identified 85 377 older patients (mean age: 76.5 years) who initiated HD; of these, 14.3% were subsequently diagnosed with AF (14.9% thereof as primary diagnosis) and 49.8% died during follow-up. Incident AF was associated with nine times higher adjusted mortality during the first 30 days [9.2 (8.8-9.6)], 5-fold higher mortality between 31 and 90 days [4.6 (4.3-4.8)] and double the mortality beyond 90 days from first AF diagnosis [2.2 (2.1-2.3)]. Incident AF was similarly associated with higher adjusted risk of ischemic stroke: 2.1 (1.6-2.7) during the first 30 days, 2.5 (2.0-3.0) between 31 and 90 days and 1.5 (1.3-1.7) beyond 90 days. Similar findings were obtained for MI. However, the risk of hip fracture was only marginally increased following AF diagnosis [≤30 days: 1.1 (0.7-1.6); 31-90 days: 1.4 (1.0-1.8); >90 days: 1.2 (1.1-1.4)]. All associations were attenuated and the association with hip fracture was null when incident AF was defined by a primary diagnosis code. Conclusions: AF was strongly associated with increased risks of ischemic stroke, MI and death, with risks highest soon after AF diagnosis but extending beyond 90 days.
Background: Little is known about the cardiovascular risks of incident atrial fibrillation/flutter (AF) in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD). Methods: We studied older US patients who newly initiated HD for ESRD (2006-11) and who had not previously been diagnosed with AF, stroke, myocardial infarction (MI) or hip fracture. We used Cox regression with AF as a time-varying covariate, adjusted for socio-demographic characteristics and comorbidities to estimate hazard ratios [HRs (95% confidence intervals)] for the events of ischemic stroke, MI and death. Hip fracture served as a negative control outcome. Results: We identified 85 377 older patients (mean age: 76.5 years) who initiated HD; of these, 14.3% were subsequently diagnosed with AF (14.9% thereof as primary diagnosis) and 49.8% died during follow-up. Incident AF was associated with nine times higher adjusted mortality during the first 30 days [9.2 (8.8-9.6)], 5-fold higher mortality between 31 and 90 days [4.6 (4.3-4.8)] and double the mortality beyond 90 days from first AF diagnosis [2.2 (2.1-2.3)]. Incident AF was similarly associated with higher adjusted risk of ischemic stroke: 2.1 (1.6-2.7) during the first 30 days, 2.5 (2.0-3.0) between 31 and 90 days and 1.5 (1.3-1.7) beyond 90 days. Similar findings were obtained for MI. However, the risk of hip fracture was only marginally increased following AF diagnosis [≤30 days: 1.1 (0.7-1.6); 31-90 days: 1.4 (1.0-1.8); >90 days: 1.2 (1.1-1.4)]. All associations were attenuated and the association with hip fracture was null when incident AF was defined by a primary diagnosis code. Conclusions: AF was strongly associated with increased risks of ischemic stroke, MI and death, with risks highest soon after AF diagnosis but extending beyond 90 days.
Authors: Pongthorn Narongroeknawin; Nivedita M Patkar; Bita Shakoory; Archana Jain; Jeffrey R Curtis; Elizabeth Delzell; Philip H Lander; Robert R Lopez-Ben; Michael J Pitt; Monika M Safford; David A Volgas; Kenneth G Saag Journal: J Clin Densitom Date: 2011-11-09 Impact factor: 2.617
Authors: Mitesh Shah; Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Helen Guo; Louise Pilote Journal: Circulation Date: 2014-01-22 Impact factor: 29.690
Authors: Paul N Jensen; Karin Johnson; James Floyd; Susan R Heckbert; Ryan Carnahan; Sascha Dublin Journal: Pharmacoepidemiol Drug Saf Date: 2012-01 Impact factor: 2.890
Authors: Jenny I Shen; Maria E Montez-Rath; Colin R Lenihan; Mintu P Turakhia; Tara I Chang; Wolfgang C Winkelmayer Journal: Am J Kidney Dis Date: 2015-07-07 Impact factor: 8.860
Authors: Benjamin A Goldstein; Cristina M Arce; Mark A Hlatky; Mintu Turakhia; Soko Setoguchi; Wolfgang C Winkelmayer Journal: Circulation Date: 2012-10-02 Impact factor: 29.690
Authors: Stephen L Seliger; Daniel L Gillen; W T Longstreth; Bryan Kestenbaum; Catherine O Stehman-Breen Journal: Kidney Int Date: 2003-08 Impact factor: 10.612
Authors: James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind Phadnis; Sally K Rigler; Purna Mukhopadhyay; John A Spertus; Xinhua Zhou; Qingjiang Hou; Theresa I Shireman Journal: Ann Epidemiol Date: 2013-01-16 Impact factor: 3.797
Authors: Jingbo Niu; Maulin K Shah; Jose J Perez; Medha Airy; Sankar D Navaneethan; Mintu P Turakhia; Tara I Chang; Wolfgang C Winkelmayer Journal: Am J Kidney Dis Date: 2018-11-16 Impact factor: 8.860
Authors: Samaya Anumudu; Medha Airy; Kevin F Erickson; Sankar D Navaneethan; Tara I Chang; Wolfgang C Winkelmayer; Jingbo Niu Journal: Kidney Int Rep Date: 2019-02-13
Authors: Mark Findlay; Rachael MacIsaac; Mary Joan MacLeod; Wendy Metcalfe; Manish M Sood; Jamie P Traynor; Jesse Dawson; Patrick B Mark Journal: Can J Kidney Health Dis Date: 2019-09-27
Authors: Jennifer E Flythe; Sai Liu; Maria E Montez-Rath; Wolfgang C Winkelmayer; Tara I Chang Journal: Nephrol Dial Transplant Date: 2021-11-09 Impact factor: 7.186